Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.45
-0.40 (-6.84%)
At close: May 30, 2025, 4:00 PM
5.50
+0.05 (0.92%)
After-hours: May 30, 2025, 7:25 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $273.06 million as of May 30, 2025. Its market cap has decreased by -8.78% in one year.
Market Cap
273.06M
Enterprise Value
198.32M
1-Year Change
-8.78%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $273.06M, an increase of 22.79%. That is a compound annual growth rate of 5.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 293.10M | -20.50% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.90B |
| Johnson & Johnson | 365.94B |
| AbbVie | 324.65B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 271.52B |
| Abbott Laboratories | 230.32B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |